Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. - Wikidata - awgldk - TriplyDB

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.

http://www.wikidata.org/entity/Q44344913

about

Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction The genetics of substance dependence OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths Symbiotic relationship of pharmacogenetics and drugs of abuse.Introduction to deep sequencing and its application to drug addiction research with a focus on rare variants.Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury.Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.Pharmacotherapy in the treatment of addiction: methadone.OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome.Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence.Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?Mu opioid receptor gene: new point mutations in opioid addicts.Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers.Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts.Genomewide linkage scan for opioid dependence and related traits Haplotype block structure of the genomic region of the mu opioid receptor gene.Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study.Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence.Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice Genetics of drug dependence Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis.Pharmacogenetic approaches to the treatment of alcohol addiction.Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment.Substance dependence low-density whole genome association study in two distinct American populations Neurobiology of addiction: treatment and public policy ramifications.Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression.Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis.The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse.Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors.Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?Morphine-induced antinociception and reward in "humanized" mice expressing the mu opioid receptor A118G polymorphism Case-control association study of WLS variants in opioid and cocaine addicted populations.

P2860

Q21284753-13A06AE5-B193-4A44-B730-3C13106BC576 Q26864309-9613A1C7-6441-46E6-9FDE-70E961D34D14 Q27002251-1625BEC6-CF68-46A2-B728-77D2505FB835 Q28289166-4A516593-D3E3-4C20-AFBD-36BC8F274847 Q28476270-DF9F1287-F402-4A60-820B-64E10E188BF2 Q30408390-5223CB37-0743-45A8-B7D7-DE6DEC8B3B43 Q33600448-5DB8A790-1258-433C-B39F-E3EA4A2DE560 Q33643136-76AA43EB-259F-41AA-9F2A-22B9AE3C84CE Q33914167-89954B37-F643-4A29-9019-7E9480C4E0AF Q33921223-72D6F217-0C53-4A46-B8D5-3C6752A15027 Q33940215-224CDB35-22C8-416C-B6C7-F2B814A6486C Q34081859-4B915EBE-1218-4A11-8546-843D49DBC90B Q34139876-BFB77A06-7039-4000-9E30-D14A4BBE3E11 Q34358797-D4CAAD3D-9D7B-4468-AFC9-22BD0BB3AC7C Q34368193-8AD37ED8-29ED-4D30-B97A-30D521F7B427 Q34651031-4A9A0169-68C3-4725-8C2F-AFFD5D5C5E32 Q34656790-17613994-1364-4102-A53E-9F754B23A773 Q34658100-03842BFB-89DD-48AC-8456-7E656B9022E3 Q34786964-0B840337-5F20-40AC-8FFC-25CA44042506 Q35005588-FAD3A8EF-1201-4C5F-BEAD-52A8AC15B475 Q35059965-BE226F6D-F396-4506-AD09-5A8A7A473D3A Q35184664-EB6AE63A-B36E-4C0F-B93F-85278767F46B Q35189955-C5CE4E18-FFFD-407B-929B-EF2272EB164A Q35199976-D7D0A1EC-1FD3-4AE8-A552-97A0AF51A28E Q35237159-B6C78502-EB39-4811-B97A-E95565DD555C Q36050631-3861D11E-B347-4569-99BF-44A26849BF88 Q36126591-71D4CCD0-5293-40BD-8BB2-E4901DD2E7A1 Q36153919-7EC1A266-9CAF-4004-AC8F-991159D6C2F9 Q36190402-7A66BC4E-AC20-4397-8BD7-76DE8D90FD24 Q36298347-7CFAEE2A-DD92-44EC-872A-19F919E49E68 Q36393054-585EE82A-BF9C-4D9C-93C1-63CC9CEEE9A4 Q36431241-4EA41732-D06E-4BBF-AD61-4508697AA75E Q36441434-1A2861ED-BEC2-4AEE-B06B-86D2920CEE09 Q36453613-FE41ACF3-AF1E-4D91-9970-259B137964DC Q36499673-77957CAB-7B0C-470E-90DF-1A14933C394C Q36639796-97375FBA-6769-4157-944C-61A89ACB8412 Q36798293-006B8F52-E07E-4D3C-ACB4-AC0F6B9B9285 Q36821195-5F20B5E6-CC69-4F83-BEB3-9E844D7979C0 Q36844846-7E073A10-4CC2-42C0-8039-FFD71335204A Q36881320-18A748EC-910E-4921-8288-BF78E721AFFD

P2860

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.

http://www.wikidata.org/entity/Q44344913

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Substantial attributable risk ...... n addiction in central Sweden.

@en

Substantial attributable risk ...... n addiction in central Sweden.

@nl

type

label

Substantial attributable risk ...... n addiction in central Sweden.

@en

Substantial attributable risk ...... n addiction in central Sweden.

@nl

prefLabel

Substantial attributable risk ...... n addiction in central Sweden.

@en

Substantial attributable risk ...... n addiction in central Sweden.

@nl

P1433

Q44344913-532564BF-0AEB-41B9-91ED-FA2764245B8B

P1476

Q44344913-E3B4C90B-7F7D-4B22-99DD-5C475C84EA80

P2093

Q44344913-0A58E1D5-135A-4841-B5FA-0571B94EF7A2

Q44344913-1FF09DE0-3299-4732-9410-34EEAAC2B322

Q44344913-427965AF-59E3-46F4-A504-0ACEE7C16E82

Q44344913-6BD5382C-4036-4FC9-82EE-23B817EDE9C9

Q44344913-B0BBDDE1-057A-4779-A9DA-F967F34B04C0

Q44344913-E8EFF2DF-7B86-43BA-A910-FF63C19CCD4D

Q44344913-EE04882E-259E-41BB-951C-ACBB5C93F166

P2860

Q44344913-0DE23ABB-5C43-4ACD-A731-375F34F4A987

Q44344913-139C4048-368F-4B82-8F7C-9BA5188477A2

Q44344913-291E69EA-9E60-4C7D-9016-1BD64F9D2D42

Q44344913-39C22955-0AED-4DC1-8EF3-C67EE8B86462

Q44344913-84784EDE-64B6-4302-8697-C18CFC399910

Q44344913-9940DC21-CF69-4080-AAD9-0BE3F78C897B

Q44344913-99C8A115-689B-4898-9164-D3A1FA76A3AA

Q44344913-9AD060C0-9C72-4234-B4A6-E2A97EE54152

Q44344913-A8CAF484-5F06-41BC-9956-E84EDEC7BC7E

Q44344913-D3E7B5B2-3859-4626-891A-9AA899B04CBF

P2888

Q44344913-16722E1F-00F4-415D-93F1-2D2E9D4AB9B1

P304

Q44344913-C7A26C0F-5136-4E56-A1F8-538C85BB2FEE

P31

Q44344913-254B54BA-4EE2-4E98-BD6B-A67A1969E0D7

P356

Q44344913-9F5FC377-97C4-4CCA-956F-0E6E4E8C1B91

P407

Q44344913-6CE1E434-32C8-4969-B902-562BF326DEAB

P433

Q44344913-A7DB0F6D-ECB7-4F6A-94AE-A6BFB0BCA0BF

P478

Q44344913-527CDEC4-7E1E-49F1-A46B-6FDF733FB6CC

P577

Q44344913-802E8D7B-C49D-48DD-AB62-88EBB878141A

P5875

Q44344913-30959D52-8447-4EAE-9D78-EC12BF935975

P6179

Q44344913-0E8AD2C6-D1D3-4382-9CE3-A5A05D095B44

P698

Q44344913-F0A36626-AC8E-488C-A15D-0D9DE13944AD

P921

Q44344913-011856E5-D3C2-4C66-9486-19D81083E4D0

Q44344913-F55AA577-F2BD-4AF5-8B2F-F2054491AB1F

P932

Q44344913-954F64E5-8550-4ED3-83E0-AE18C5A5787B

P356

P1433

Molecular Psychiatry

P1476

Substantial attributable risk ...... n addiction in central Sweden.

@en

P2093

Bart G

http://www.w3.org/2001/XMLSchema#string

Heilig M

http://www.w3.org/2001/XMLSchema#string

Kreek MJ

http://www.w3.org/2001/XMLSchema#string

LaForge KS

http://www.w3.org/2001/XMLSchema#string

Leal SM

http://www.w3.org/2001/XMLSchema#string

Ott J

http://www.w3.org/2001/XMLSchema#string

Pollak L

http://www.w3.org/2001/XMLSchema#string

P2860

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

Opioid receptor and peptide gene polymorphisms: potential implications for addictions.

Pharmacotherapy of addictions.

Chromosome mapping of gene loci affecting morphine and amphetamine responses in BXD recombinant inbred mice.

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.

Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities.

The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade.

Morphine self-administration in mu-opioid receptor-deficient mice.

Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1).

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.

P2888

P304

547-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.MP.4001504

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8662595

http://www.w3.org/2001/XMLSchema#string

P6179

1008444376

http://www.w3.org/2001/XMLSchema#string

P698

15037869

http://www.w3.org/2001/XMLSchema#string

P921

P932

6141020

http://www.w3.org/2001/XMLSchema#string